CalciMedica is trading 10.87% higher at $1.27, with no clear reason identified for its October 22 move. - No new company-specific announcement was identified; its investor-relations press-release page lists an earlier reverse stock split, not a new announcement for October 22. - Broader U.S. markets were weaker, and the cited biotech ETF was also slightly lower pre-market; neither signal explains the stock’s rise.